Lead Singer of The Chordaes Discovers the Power of Pot

During a recent interview, the lead singer of The Chordaes, Leo Sawikin, opened up about how using pot for ADD has changed his creative process.

By
Jeff Siegel

Medication is rarely a one-size-fits-all solution, especially when it comes to ADD, where oftentimes conventional pharmaceuticals just fall short. For instance, I have one friend who traded in her Adderall and Ritalin for a high-protein/low-sugar diet and a steady fitness regimen, which also includes yoga and meditation. She’s been “pill-free” for three years now. I also know plenty of folks who have found respite through cannabis consumption. Take Leo Sawikin, the lead vocalist of the indie band The Chordaes.

Leo recently opened up to me about this very thing in a recent interview.

While I was originally intrigued by the band’s latest release, “What Do You Want from Me,” I found myself equally interested in his relationship with cannabis.

You see, like many folks beset by ADD, Sawikin relied upon a conventional ADD medication to manage his symptoms. For him, it was Vyvance, although there are plenty of other medications available in pharmacies all across the country. 

Sadly, many of those medications also come with all kinds of negative side effects, including sleeplessness and anxiety.

Fortunately for Leo, however, he was introduced to cannabis by a close friend who not only schooled Sawikin on the benefits of cannabis but also had access to a variety of strains that allowed Leo to find the right one for him.

Today, Leo successfully manages his ADD with his favorite strain, Cannatonic, which has a fairly high CBD content and is used quite often to treat things like anxiety, migraines and OCD.

He tells me his favorite method of consumption is the tried and true joint, using only RAW unbleached rolling papers, saying, For me, the consistency is just better with joints.

While Cannatonic works well for Leo, there are plenty of other strains that have been known to help folks with ADD, such as Super Sour Diesel, Haze and Hawaiian Snow.

Of course, like most musicians, Leo has also found cannabis to aid in the creative process.

“Cannabis definitely helps me with the creative process,” he said. “It helps me create in a more organic way. My songs now have their own souls.”

Leo wouldn’t be the only musician to suggest such a thing, as artists have long used cannabis as a way to boost focus and creativity. I would actually argue that some of the most influential musicians of all time were (and still are in many cases) cannabis consumers: Miles Davis, Louis Armstrong, Bob Marley, Jimi Hendrix, Bob Dylan, Patti Smith, HR of the Bad Brains, the list goes on an on.

What makes Sawikin’s story so interesting, however, is that he initially used cannabis to treat his ADD, and later found that it could also assist in the creative process. 

And this begs the question: Will more and more folks with ADD using cannabis as a treatment be able to enhance their own creative processes? Yes, dear reader, these are the kinds of things I think about—even when I’m not high.

In any event, cannabis has clearly worked wonders for Leo Sawikin, not only as a treatment for ADD but also as a way to make some pretty good music. You can check out The Chordaes’ latest release, “What Do You Want from Me,” here. You can also see the Chordaes live, and get a chance to meet Leo, on October 31, at the Rockwood in New York.

Jeff Siegel

Jeff Siegel's been active in the financial publishing business since the mid-90s. A true capitalist, Jeff has made his fortune in what's known as socially-responsible investing, focusing primarily on alternative energy and transportation markets, sustainability, legal cannabis, and agriculture. He's a regular on the conference circuit, and every now and then you might find him appearing on Fox, CNBC, or Bloomberg. From 1994 to 2001, Jeff worked for Agora Publishing, one of the largest financial newsletter publishers in the world, before packing his bags and traveling across the globe in search of mega-trends and his own version of nirvana... He found both in the world of "green" markets. Jeff's early analyses of alternative energy and socially-responsible investing drew much criticism from the status quo. His unapologetic capitalist spirit, and abrasive nature didn't earn him many accolades from colleagues, either... But after accurately predicting dozens of trends in the ever-changing landscape of "green" market investing, many have since traded their preconceptions of socially-responsible investing for profits. Often declaring, “Capitalism is a catalyst for positive change,” Jeff continues to spot the most lucrative renewable energy, organic food and cannabis companies in the world. And his thousands of loyal readers have made small fortunes in the process. Each week, Jeff shares the latest in "green" market news as well as his own market updates and recommendations. Jeff also works as a consultant, has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling energy book, Investing in Renewable Energy: Making Money on Green Chip Stocks and is the co-author of Energy Investing for Dummies. http://www.wealthdaily.com/editors/jeff-siegel

By
Jeff Siegel
Tags: Addiction

Recent Posts

Connecticut House Approve Bill Regulating Hemp Products

Connecticut lawmakers have passed legislation to regulate hemp products, including a provision that sets a…

4 hours ago

Hemp Clothing Market to Hit $23B by 2031, Report Predicts

The hemp clothing industry is making a resurgence as a popular textile choice.

4 hours ago

Clinical Trial To Assess LSD Microdosing For PMS

An Australian biopharma company said Thursday that it has received approval to begin a series…

4 hours ago

Friends Don’t Let Friends Jump Through Loopholes

It’s time to take a stand against gas station weed.

4 hours ago

Survey: High-THC Flower Yields Few Serious Side Effects in Patients

Medical cannabis patients who were administered high-THC marijuana flower found the experience to be both…

4 hours ago

Cannabis Community, Investors React to DEA Decision To Reschedule

Cannabis advocates hailed the DEA’s decision to reclassify marijuana under federal drugs laws, although many…

1 day ago